Selected research
Market Structure
Global Gleevec Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gleevec market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gleevec include Novartis. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gleevec market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gleevec and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gleevec sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gleevec market size, projected growth trends, production technologies, key applications, and end-use industries.
Gleevec Segment by Company
Novartis
Gleevec Segment by Type
400mg
100mg
Gleevec Segment by Application
Hospital
Pharmacy
Gleevec Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gleevec market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gleevec and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gleevec.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gleevec market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gleevec manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gleevec in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gleevec in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 400mg
- 100mg
Applications
- Hospital
- Pharmacy
Companies covered
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gleevec Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gleevec Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gleevec Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gleevec Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gleevec Market Dynamics
- 2.1 Gleevec Industry Trends
- 2.2 Gleevec Industry Drivers
- 2.3 Gleevec Industry Opportunities and Challenges
- 2.4 Gleevec Industry Restraints
3 Gleevec Market by Manufacturers
- 3.1 Global Gleevec Revenue by Manufacturers (2021-2026)
- 3.2 Global Gleevec Sales by Manufacturers (2021-2026)
- 3.3 Global Gleevec Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gleevec Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gleevec Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gleevec Manufacturers, Product Type & Application
- 3.7 Global Gleevec Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gleevec Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gleevec Players Market Share by Revenue in 2025
- 3.8.3 2025 Gleevec Tier 1, Tier 2, and Tier 3
4 Gleevec Market by Type
- 4.1 Gleevec Type Introduction
- 4.1.1 400mg
- 4.1.2 100mg
- 4.2 Global Gleevec Sales by Type
- 4.2.1 Global Gleevec Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gleevec Sales by Type (2021-2032)
- 4.2.3 Global Gleevec Sales Market Share by Type (2021-2032)
- 4.3 Global Gleevec Revenue by Type
- 4.3.1 Global Gleevec Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gleevec Revenue by Type (2021-2032)
- 4.3.3 Global Gleevec Revenue Market Share by Type (2021-2032)
5 Gleevec Market by Application
- 5.1 Gleevec Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global Gleevec Sales by Application
- 5.2.1 Global Gleevec Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gleevec Sales by Application (2021-2032)
- 5.2.3 Global Gleevec Sales Market Share by Application (2021-2032)
- 5.3 Global Gleevec Revenue by Application
- 5.3.1 Global Gleevec Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gleevec Revenue by Application (2021-2032)
- 5.3.3 Global Gleevec Revenue Market Share by Application (2021-2032)
6 Global Gleevec Sales by Region
- 6.1 Global Gleevec Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gleevec Sales by Region (2021-2032)
- 6.2.1 Global Gleevec Sales by Region (2021-2026)
- 6.2.2 Global Gleevec Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gleevec Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gleevec Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gleevec Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gleevec Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gleevec Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gleevec Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gleevec Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gleevec Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gleevec Revenue by Region
- 7.1 Global Gleevec Revenue by Region
- 7.1.1 Global Gleevec Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gleevec Revenue by Region (2021-2026)
- 7.1.3 Global Gleevec Revenue by Region (2027-2032)
- 7.1.4 Global Gleevec Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gleevec Revenue (2021-2032)
- 7.2.2 North America Gleevec Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gleevec Revenue (2021-2032)
- 7.3.2 Europe Gleevec Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gleevec Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gleevec Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gleevec Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gleevec Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Gleevec Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Gleevec Product Portfolio
- 8.1.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gleevec Value Chain Analysis
- 9.1.1 Gleevec Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gleevec Production Mode & Process
- 9.2 Gleevec Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gleevec Distributors
- 9.2.3 Gleevec Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst